Cargando…

Encapsulation of Rat Bone Marrow Derived Mesenchymal Stem Cells in Alginate Dialdehyde/Gelatin Microbeads with and without Nanoscaled Bioactive Glass for In Vivo Bone Tissue Engineering

Alginate dialdehyde (ADA), gelatin, and nano-scaled bioactive glass (nBG) particles are being currently investigated for their potential use as three-dimensional scaffolding materials for bone tissue engineering. ADA and gelatin provide a three-dimensional scaffold with properties supporting cell ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Rottensteiner-Brandl, Ulrike, Detsch, Rainer, Sarker, Bapi, Lingens, Lara, Köhn, Katrin, Kneser, Ulrich, Bosserhoff, Anja K., Horch, Raymund E., Boccaccini, Aldo R., Arkudas, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213117/
https://www.ncbi.nlm.nih.gov/pubmed/30275427
http://dx.doi.org/10.3390/ma11101880
_version_ 1783367696765681664
author Rottensteiner-Brandl, Ulrike
Detsch, Rainer
Sarker, Bapi
Lingens, Lara
Köhn, Katrin
Kneser, Ulrich
Bosserhoff, Anja K.
Horch, Raymund E.
Boccaccini, Aldo R.
Arkudas, Andreas
author_facet Rottensteiner-Brandl, Ulrike
Detsch, Rainer
Sarker, Bapi
Lingens, Lara
Köhn, Katrin
Kneser, Ulrich
Bosserhoff, Anja K.
Horch, Raymund E.
Boccaccini, Aldo R.
Arkudas, Andreas
author_sort Rottensteiner-Brandl, Ulrike
collection PubMed
description Alginate dialdehyde (ADA), gelatin, and nano-scaled bioactive glass (nBG) particles are being currently investigated for their potential use as three-dimensional scaffolding materials for bone tissue engineering. ADA and gelatin provide a three-dimensional scaffold with properties supporting cell adhesion and proliferation. Combined with nanocristalline BG, this composition closely mimics the mineral phase of bone. In the present study, rat bone marrow derived mesenchymal stem cells (MSCs), commonly used as an osteogenic cell source, were evaluated after encapsulation into ADA-gelatin hydrogel with and without nBG. High cell survival was found in vitro for up to 28 days with or without addition of nBG assessed by calcein staining, proving the cell-friendly encapsulation process. After subcutaneous implantation into rats, survival was assessed by DAPI/TUNEL fluorescence staining. Hematoxylin-eosin staining and immunohistochemical staining for the macrophage marker ED1 (CD68) and the endothelial cell marker lectin were used to evaluate immune reaction and vascularization. After in vivo implantation, high cell survival was found after 1 week, with a notable decrease after 4 weeks. Immune reaction was very mild, proving the biocompatibility of the material. Angiogenesis in implanted constructs was significantly improved by cell encapsulation, compared to cell-free beads, as the implanted MSCs were able to attract endothelial cells. Constructs with nBG showed higher numbers of vital MSCs and lectin positive endothelial cells, thus showing a higher degree of angiogenesis, although this difference was not significant. These results support the use of ADA/gelatin/nBG as a scaffold and of MSCs as a source of osteogenic cells for bone tissue engineering. Future studies should however improve long term cell survival and focus on differentiation potential of encapsulated cells in vivo.
format Online
Article
Text
id pubmed-6213117
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62131172018-11-14 Encapsulation of Rat Bone Marrow Derived Mesenchymal Stem Cells in Alginate Dialdehyde/Gelatin Microbeads with and without Nanoscaled Bioactive Glass for In Vivo Bone Tissue Engineering Rottensteiner-Brandl, Ulrike Detsch, Rainer Sarker, Bapi Lingens, Lara Köhn, Katrin Kneser, Ulrich Bosserhoff, Anja K. Horch, Raymund E. Boccaccini, Aldo R. Arkudas, Andreas Materials (Basel) Article Alginate dialdehyde (ADA), gelatin, and nano-scaled bioactive glass (nBG) particles are being currently investigated for their potential use as three-dimensional scaffolding materials for bone tissue engineering. ADA and gelatin provide a three-dimensional scaffold with properties supporting cell adhesion and proliferation. Combined with nanocristalline BG, this composition closely mimics the mineral phase of bone. In the present study, rat bone marrow derived mesenchymal stem cells (MSCs), commonly used as an osteogenic cell source, were evaluated after encapsulation into ADA-gelatin hydrogel with and without nBG. High cell survival was found in vitro for up to 28 days with or without addition of nBG assessed by calcein staining, proving the cell-friendly encapsulation process. After subcutaneous implantation into rats, survival was assessed by DAPI/TUNEL fluorescence staining. Hematoxylin-eosin staining and immunohistochemical staining for the macrophage marker ED1 (CD68) and the endothelial cell marker lectin were used to evaluate immune reaction and vascularization. After in vivo implantation, high cell survival was found after 1 week, with a notable decrease after 4 weeks. Immune reaction was very mild, proving the biocompatibility of the material. Angiogenesis in implanted constructs was significantly improved by cell encapsulation, compared to cell-free beads, as the implanted MSCs were able to attract endothelial cells. Constructs with nBG showed higher numbers of vital MSCs and lectin positive endothelial cells, thus showing a higher degree of angiogenesis, although this difference was not significant. These results support the use of ADA/gelatin/nBG as a scaffold and of MSCs as a source of osteogenic cells for bone tissue engineering. Future studies should however improve long term cell survival and focus on differentiation potential of encapsulated cells in vivo. MDPI 2018-10-01 /pmc/articles/PMC6213117/ /pubmed/30275427 http://dx.doi.org/10.3390/ma11101880 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rottensteiner-Brandl, Ulrike
Detsch, Rainer
Sarker, Bapi
Lingens, Lara
Köhn, Katrin
Kneser, Ulrich
Bosserhoff, Anja K.
Horch, Raymund E.
Boccaccini, Aldo R.
Arkudas, Andreas
Encapsulation of Rat Bone Marrow Derived Mesenchymal Stem Cells in Alginate Dialdehyde/Gelatin Microbeads with and without Nanoscaled Bioactive Glass for In Vivo Bone Tissue Engineering
title Encapsulation of Rat Bone Marrow Derived Mesenchymal Stem Cells in Alginate Dialdehyde/Gelatin Microbeads with and without Nanoscaled Bioactive Glass for In Vivo Bone Tissue Engineering
title_full Encapsulation of Rat Bone Marrow Derived Mesenchymal Stem Cells in Alginate Dialdehyde/Gelatin Microbeads with and without Nanoscaled Bioactive Glass for In Vivo Bone Tissue Engineering
title_fullStr Encapsulation of Rat Bone Marrow Derived Mesenchymal Stem Cells in Alginate Dialdehyde/Gelatin Microbeads with and without Nanoscaled Bioactive Glass for In Vivo Bone Tissue Engineering
title_full_unstemmed Encapsulation of Rat Bone Marrow Derived Mesenchymal Stem Cells in Alginate Dialdehyde/Gelatin Microbeads with and without Nanoscaled Bioactive Glass for In Vivo Bone Tissue Engineering
title_short Encapsulation of Rat Bone Marrow Derived Mesenchymal Stem Cells in Alginate Dialdehyde/Gelatin Microbeads with and without Nanoscaled Bioactive Glass for In Vivo Bone Tissue Engineering
title_sort encapsulation of rat bone marrow derived mesenchymal stem cells in alginate dialdehyde/gelatin microbeads with and without nanoscaled bioactive glass for in vivo bone tissue engineering
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213117/
https://www.ncbi.nlm.nih.gov/pubmed/30275427
http://dx.doi.org/10.3390/ma11101880
work_keys_str_mv AT rottensteinerbrandlulrike encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering
AT detschrainer encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering
AT sarkerbapi encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering
AT lingenslara encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering
AT kohnkatrin encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering
AT kneserulrich encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering
AT bosserhoffanjak encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering
AT horchraymunde encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering
AT boccaccinialdor encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering
AT arkudasandreas encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering